AA
61
-2
BA
39
3
CMCSA
59
2
APH
55
-4
IRM
71
-2
DRI
58
-2
SLB
57
4
GIS
49
6
IVZ
63
-3
HPQ
63
-7
CNP
65
2
MHK
56
3
ZBH
53
-3
TAP
53
5
MTCH
55
5
XRX
55
3
MMM
52
-5
JWN
53
-4
KO
50
4
CHD
58
5
AA
61
-2
BA
39
3
CMCSA
59
2
APH
55
-4
IRM
71
-2
DRI
58
-2
SLB
57
4
GIS
49
6
IVZ
63
-3
HPQ
63
-7
CNP
65
2
MHK
56
3
ZBH
53
-3
TAP
53
5
MTCH
55
5
XRX
55
3
MMM
52
-5
JWN
53
-4
KO
50
4
CHD
58
5
Financhill
Back

Central Garden & Pet Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
53

CENTA
Central Garden & Pet

Last Price:
31.78
Seasonality Move:
0.75%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Buy
53
Central Garden & Pet (CENTA) is a Buy

Is Central Garden & Pet a Buy, Sell or Hold?

  • The current Central Garden & Pet [CENTA] share price is $31.77. The Score for CENTA is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • CENTA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CENTA Stock Price Chart

What is Central Garden & Pet's stock price today?

  • The Central Garden & Pet share price today is $31.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CENTA is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

CENTA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.42 Sell
Relative Strength Index (14 RSI): 37.98 Sell
Chaikin Money Flow: -227302 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.2 - 33.98) Sell
Bollinger Bands (100): (32.09 - 36.89) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

CENTA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.41 Sell
20-day SMA: 32.79 Sell
50-day SMA: 33.34 Sell
200-day SMA: 34.87 Sell
8-day EMA: 32.23 Sell
20-day EMA: 32.69 Sell
50-day EMA: 33.26 Sell
200-day EMA: 33.96 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

Central Garden & Pet Earnings Growth & CENTA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.46 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Central Garden & Pet Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):